New diabetes pill combo tested for better blood sugar control
NCT ID NCT00974090
Summary
This study tested if adding a new drug called Teneligliptin (MP-513) to an existing Sulfonylurea medication was safe and effective for controlling blood sugar in Japanese adults with type 2 diabetes. It involved 194 participants and measured changes in key blood sugar markers over 12 weeks, with some continuing for up to a year. The goal was to see if this combination could help people manage their diabetes better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Sapporo, Hokkaido, Japan
Conditions
Explore the condition pages connected to this study.